SARA BELL: Open Payments
NPI 1245705896 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 75 payments from 24 companies in 2025. Trend: 2023 $1,210 · 2024 $950 · 2025 $1,862
Food & beverage: $1,657Education: $205
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $172 |
| Gilead Sciences, Inc. | 5 | $167 |
| Daiichi Sankyo Inc. | 7 | $153 |
| Celgene Corporation | 5 | $144 |
| AstraZeneca Pharmaceuticals LP | 6 | $126 |
| E.R. Squibb & Sons, L.L.C. | 6 | $116 |
| SOBI, INC | 2 | $108 |
| PFIZER INC. | 5 | $97 |
| Genentech USA, Inc. | 4 | $96 |
| GlaxoSmithKline, LLC. | 4 | $86 |
Products named: RYBREVANT, Trodelvy, Enhertu, Doptelet, IMBRUVICA, OPDUALAG, OPDIVO, REBLOZYL.
Industry payments across SC — which companies pay providers there.
